Shahrokh Taghavi Selected Research

Shahrokh Taghavi Research Topics

Disease

5	Pulmonary Hypertension 06/2022 - 04/2010
5	Primary Graft Dysfunction 01/2021 - 07/2007
4	Hypoxia (Hypoxemia) 03/2015 - 05/2002
4	Bronchiolitis Obliterans 07/2014 - 06/2005
3	Neoplasms (Cancer) 01/2021 - 07/2008
3	Infections 01/2019 - 05/2004
3	Bronchiolitis Obliterans Syndrome 07/2014 - 01/2008
3	Chronic Obstructive Pulmonary Disease (COPD) 01/2009 - 05/2004
2	Wounds and Injuries (Trauma) 11/2022 - 01/2021
2	Thrombosis (Thrombus) 01/2021 - 01/2018
2	Lung Diseases (Lung Disease) 05/2019 - 05/2004
2	Lung Neoplasms (Lung Cancer) 01/2016 - 01/2005
2	Cystic Fibrosis (Mucoviscidosis) 07/2007 - 05/2004
2	Acute Lung Injury 05/2004 - 06/2002
1	Heart Failure 06/2022
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 03/2022
1	COVID-19 03/2022
1	Empyema 01/2021
1	Brain Death (Brain Dead) 05/2019
1	Death (Near-Death Experience) 05/2019
1	Chronic Renal Insufficiency 01/2019
1	Bronchiolitis 01/2019
1	Familial Primary Pulmonary Hypertension 01/2018
1	Inflammation (Inflammations) 01/2018
1	Pulmonary Edema 09/2017
1	Ulcer 10/2016
1	Diabetic Foot 10/2016
1	Pulmonary Alveolar Microlithiasis 04/2016
1	Sepsis (Septicemia) 04/2016
1	Residual Neoplasm 05/2015
1	Acidosis 03/2015
1	Hypercapnia 03/2015
1	Shock 03/2015
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 07/2014
1	Neointima 01/2014
1	Diabetes Mellitus 08/2012
1	Embolism (Embolus) 04/2012
1	Malignant Mesothelioma 07/2008
1	Cyanosis 02/2008
1	Carcinoid Tumor (Carcinoid) 02/2008
1	Pathologic Constriction (Stenosis) 01/2008
1	Fistula 01/2005
1	Fibrosis (Cirrhosis) 05/2004
1	Lung Injury 06/2002
1	Edema (Dropsy) 06/2002

Drug/Important Bio-Agent (IBA)

4	Prostaglandins DIBA 01/2021 - 07/2007
3	Biomarkers (Surrogate Marker)IBA 01/2018 - 01/2009
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 07/2007 - 05/2002
2	C-Reactive ProteinIBA 01/2018 - 01/2009
2	Endothelin-1 (Endothelin 1)IBA 07/2011 - 12/2010
1	Indicators and Reagents (Reagents)IBA 06/2022
1	Carbon DioxideIBA 01/2021
1	dicarboxydine (DCD)IBA 05/2019
1	Alemtuzumab (Campath)FDA Link 01/2019
1	fibrin fragment D (D-dimer)IBA 01/2018
1	FibrinIBA 01/2018
1	Epithelial Sodium ChannelsIBA 09/2017
1	Cisplatin (Platino)FDA LinkGeneric 05/2015
1	Glycoproteins (Glycoprotein)IBA 07/2014
1	ChitinasesIBA 07/2014
1	VimentinIBA 01/2014
1	HMGB1 Protein (HMG1)IBA 01/2014
1	Tacrolimus (Prograf)FDA LinkGeneric 08/2012
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2009
1	Interleukin-6 (Interleukin 6)IBA 01/2009
1	AsbestosIBA 07/2008
1	AngiopoietinsIBA 07/2007
1	ImmunosorbentsIBA 07/2007
1	EnzymesIBA 07/2007
1	ProdrugsIBA 07/2005
1	Valganciclovir FDA Link 07/2005
1	Ganciclovir (Cytovene)FDA LinkGeneric 07/2005
1	Metalloproteases (Metalloproteinases)IBA 06/2005
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 05/2004
1	Vascular Endothelial Growth Factor CIBA 06/2002

Therapy/Procedure

16	Lung Transplantation 03/2022 - 05/2002
5	Transplantation 01/2019 - 06/2002
4	Therapeutics 06/2022 - 07/2005
4	Endarterectomy (Thromboendarterectomy) 06/2022 - 04/2010
4	Pneumonectomy (Lung Volume Reduction) 01/2021 - 01/2005
4	Extracorporeal Membrane Oxygenation 01/2018 - 07/2011
1	Tracheostomy 11/2022
1	Ligation 01/2021
1	Cardiopulmonary Bypass (Heart-Lung Bypass) 01/2018
1	Induction Chemotherapy 05/2015
1	Kyphoplasty 04/2012